Brief: Spago Nanomedical Q1 Adj. EPS at SEK -0.16

Spago Nanomedical AB (publ)

09/05/2023 07:06

May 9 (Reuters) - Spago Nanomedical Q1 operating expenses SEK -17.168 million.
* Q1 net income SEK -14.379 million
* Q1 adjusted EPS SEK -0.16
* Q1 sales SEK 88 thousand